Mycotopia Therapies, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Aibotics, Inc. reports a net loss of $2.2 million for 2025 while pivoting its business focus toward AI-powered robotics and wellness products.
AIBotics, Inc.'s 2024 10-K filing reveals a widened net loss and a strategic shift towards artificial intelligence and robotics, particularly in the wellness and parenting sectors.
Mycotopia Therapies, Inc. reports a net loss for 2023 and a shift in business strategy towards AI-powered robotics following the acquisition of Philon Labs assets.